A retrospective cohort study to determine risk for requiring corticosteroid therapy (which is used as a proxy for immune-related adverse events) in patients treated with immune checkpoint inhibitors and radiation therapy using a nationwide patient database
Latest Information Update: 18 Oct 2021
At a glance
- Drugs Ipilimumab (Primary) ; Nivolumab (Primary) ; Pembrolizumab (Primary) ; Methylprednisolone; Prednisolone
- Indications Cancer; Lung cancer; Malignant melanoma; Solid tumours
- Focus Adverse reactions
- 18 Oct 2021 New trial record
- 11 Oct 2021 Results published in the Cancer